While the inhibition of such ligands is usually dependent on immune checkpoint monoclonal antibodies or inhibitors, EZH2 small molecule inhibitors are also synergistic and can still promote the apoptosis of tumor cells themselves. This evidence concerns the gene EZH2 and neoplasm.